Effectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF Varnish

Sponsor
The University of Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT02019160
Collaborator
(none)
1,070
1
2
45
23.8

Study Details

Study Description

Brief Summary

  • Aim: This randomised controlled trial will systematically compare the efficacy of a 25% AgNO3 solution followed by 5% NaF varnish with that of a 38% SDF solution in arresting caries teeth among preschool children when applied at half-yearly intervals over a 30-month period.

  • Method: The extension of the Consolidated Standards of Reporting Trials 2010 Statement will be followed for this 30-month, randomised, double-blinded, non-inferiority clinical trial. Approximately 2,400 kindergarten children will be screened and at least 826 children with caries will be recruited. This sample size is sufficient for an appropriate statistical analysis (power at 90% [β=0.10] with a 2-sided type-I error of α=0.05), allowing for a 18% drop-out rate. The children will be randomly allocated into 2 groups to treat their caries over a 30-month period: Group A - biannual application of a 25% AgNO3 solution followed by a 5% NaF varnish, and Group B - biannual application of a 38% SDF solution followed by a placebo varnish.Clinical examinations will be conducted at 6-month intervals to assess whether the caries are arrested. Information on confounding factors such as oral hygiene habits will be collected through a parental questionnaire.

  • Possible results and implications: As the first of its kind, this study would help to determine whether AgNO3 followed by NaF is at least as effective as SDF in arresting childhood caries. If so, because 25% AgNO3 and 5% NaF contain less silver and fluoride, respectively, than 38% SDF, their use would be more favourable than SDF in young children.

Condition or Disease Intervention/Treatment Phase
  • Drug: 25% AgNO3 solution followed by 5% NaF varnish
  • Drug: 38% SDF solution followed by placebo varnish
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
1070 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Biannual Application of Silver Nitrate Solution Followed by Sodium Fluoride Varnish in Arresting Early Childhood Caries in Preschool Children: a 30-month, Randomised, Double-blind, Non-inferiority Trial
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Jun 1, 2018
Actual Study Completion Date :
Jun 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Silver nitrate

Biannual application of 25% AgNO3 solution followed by 5% NaF varnish.

Drug: 25% AgNO3 solution followed by 5% NaF varnish
Dosage of 4.4μg±1.4μg fluoride per use
Other Names:
  • silver nitrate
  • sodium fluoride
  • Active Comparator: Silver diamine fluoride

    Biannual application of 38% SDF solution followed by placebo varnish.

    Drug: 38% SDF solution followed by placebo varnish
    Dosage of 8.8μg±2.8μg fluoride per use
    Other Names:
  • silver diamine fluoride
  • Outcome Measures

    Primary Outcome Measures

    1. The hardness of cavity on tooth by probing [The follow-up oral examinations will be conducted every 6 months for 30 months totally]

      We expect that topical application of 25% AgNO3 solution followed by 5% NaF varnish and of 38% SDF solution can both effectively arrest ECC.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Kindergarteners who have joined our outreach dental service will be invited to join this study. Preschool children aged 3-4 years who have tooth decay and are attending the first year of kindergarten will be invited to join this study.
    Exclusion Criteria:
    • Children who are uncooperative and difficult to manage, have major systemic diseases, or are on long-term medication will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of Hong Kong Hong Kong China

    Sponsors and Collaborators

    • The University of Hong Kong

    Investigators

    • Principal Investigator: Chun Hung Chu, The University of Hong Kong

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Chun-Hung Chu, Associate Professor, The University of Hong Kong
    ClinicalTrials.gov Identifier:
    NCT02019160
    Other Study ID Numbers:
    • chuch14
    First Posted:
    Dec 24, 2013
    Last Update Posted:
    Sep 26, 2019
    Last Verified:
    Sep 1, 2019
    Keywords provided by Chun-Hung Chu, Associate Professor, The University of Hong Kong
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 26, 2019